Jason J. Luke, Stéphane Dalle, Yin Wu, Oliver Edgar Bechter, Daniel Brungs, Anna Maria Di Giacomo, Hanna Eriksson, Peter Mohr, Rossanna C. Pezo, Egle Ramelyte, Bernardo Leon Rapoport, Gareth Rivalland, Amitesh Chandra Roy, Mizuho Fukunaga-Kalabis, Geetha Krishna Kaza, Yayan Zhang, Etah Kurland, Alexander M. Eggermont. "TeLuRide-006: An adaptive phase 2/3 study of EIK1001, a Toll-like receptor 7/8 (TLR7/8) agonist, in combination with pembrolizumab in patients with advanced melanoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps9604